Latham, Shearman Assist in Amgen's $4.5 Billion Financing

, The Recorder


Amgen Inc., the Thousand Oaks-based biotech firm, tapped Latham & Watkins for a $4.5 billion offering of investment-grade notes. Shearman & Sterling represented the syndicate of 18 underwriters, led by Morgan Stanley.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202656486500

Thank you!

This article's comments will be reviewed.